nodes	percent_of_prediction	percent_of_DWPC	metapath
Nizatidine—BCHE—Cisplatin—testicular cancer	0.283	0.391	CbGbCtD
Nizatidine—ABCB1—Dactinomycin—testicular cancer	0.125	0.173	CbGbCtD
Nizatidine—ABCB1—Vinblastine—testicular cancer	0.0783	0.108	CbGbCtD
Nizatidine—ABCB1—Cisplatin—testicular cancer	0.0718	0.0993	CbGbCtD
Nizatidine—ABCB1—Etoposide—testicular cancer	0.0705	0.0975	CbGbCtD
Nizatidine—ABCB1—Doxorubicin—testicular cancer	0.0481	0.0665	CbGbCtD
Nizatidine—ABCB1—Methotrexate—testicular cancer	0.0466	0.0644	CbGbCtD
Nizatidine—Myalgia—Ifosfamide—testicular cancer	0.00097	0.0035	CcSEcCtD
Nizatidine—Flatulence—Cisplatin—testicular cancer	0.000968	0.0035	CcSEcCtD
Nizatidine—Anorexia—Dactinomycin—testicular cancer	0.000967	0.00349	CcSEcCtD
Nizatidine—Diarrhoea—Chlorambucil—testicular cancer	0.000962	0.00348	CcSEcCtD
Nizatidine—Dermatitis exfoliative—Methotrexate—testicular cancer	0.000948	0.00343	CcSEcCtD
Nizatidine—Decreased appetite—Bleomycin—testicular cancer	0.000946	0.00342	CcSEcCtD
Nizatidine—Confusional state—Ifosfamide—testicular cancer	0.000938	0.00339	CcSEcCtD
Nizatidine—Pain—Bleomycin—testicular cancer	0.00093	0.00336	CcSEcCtD
Nizatidine—Anaphylactic shock—Ifosfamide—testicular cancer	0.00093	0.00336	CcSEcCtD
Nizatidine—Musculoskeletal discomfort—Dactinomycin—testicular cancer	0.000924	0.00334	CcSEcCtD
Nizatidine—Asthenia—Vinblastine—testicular cancer	0.000924	0.00334	CcSEcCtD
Nizatidine—Infection—Ifosfamide—testicular cancer	0.000924	0.00334	CcSEcCtD
Nizatidine—Thrombocytopenia—Ifosfamide—testicular cancer	0.00091	0.00329	CcSEcCtD
Nizatidine—Anaemia—Cisplatin—testicular cancer	0.000908	0.00328	CcSEcCtD
Nizatidine—Hyperhidrosis—Ifosfamide—testicular cancer	0.000899	0.00325	CcSEcCtD
Nizatidine—Feeling abnormal—Bleomycin—testicular cancer	0.000897	0.00324	CcSEcCtD
Nizatidine—Vomiting—Chlorambucil—testicular cancer	0.000894	0.00323	CcSEcCtD
Nizatidine—Dermatitis exfoliative—Epirubicin—testicular cancer	0.000888	0.00321	CcSEcCtD
Nizatidine—Anorexia—Ifosfamide—testicular cancer	0.000886	0.0032	CcSEcCtD
Nizatidine—Decreased appetite—Dactinomycin—testicular cancer	0.000882	0.00319	CcSEcCtD
Nizatidine—Diarrhoea—Vinblastine—testicular cancer	0.000881	0.00318	CcSEcCtD
Nizatidine—Back pain—Etoposide—testicular cancer	0.00087	0.00315	CcSEcCtD
Nizatidine—Pain—Dactinomycin—testicular cancer	0.000868	0.00314	CcSEcCtD
Nizatidine—Urticaria—Bleomycin—testicular cancer	0.000864	0.00312	CcSEcCtD
Nizatidine—Body temperature increased—Bleomycin—testicular cancer	0.00086	0.00311	CcSEcCtD
Nizatidine—Irritability—Methotrexate—testicular cancer	0.000854	0.00309	CcSEcCtD
Nizatidine—Dizziness—Vinblastine—testicular cancer	0.000852	0.00308	CcSEcCtD
Nizatidine—Convulsion—Cisplatin—testicular cancer	0.000851	0.00307	CcSEcCtD
Nizatidine—Musculoskeletal discomfort—Ifosfamide—testicular cancer	0.000847	0.00306	CcSEcCtD
Nizatidine—Myalgia—Cisplatin—testicular cancer	0.000836	0.00302	CcSEcCtD
Nizatidine—Feeling abnormal—Dactinomycin—testicular cancer	0.000836	0.00302	CcSEcCtD
Nizatidine—Nausea—Chlorambucil—testicular cancer	0.000835	0.00302	CcSEcCtD
Nizatidine—Anxiety—Cisplatin—testicular cancer	0.000833	0.00301	CcSEcCtD
Nizatidine—Anaemia—Etoposide—testicular cancer	0.000832	0.00301	CcSEcCtD
Nizatidine—Gastrointestinal pain—Dactinomycin—testicular cancer	0.00083	0.003	CcSEcCtD
Nizatidine—Somnolence—Ifosfamide—testicular cancer	0.000827	0.00299	CcSEcCtD
Nizatidine—Dermatitis exfoliative—Doxorubicin—testicular cancer	0.000821	0.00297	CcSEcCtD
Nizatidine—Vomiting—Vinblastine—testicular cancer	0.000819	0.00296	CcSEcCtD
Nizatidine—Decreased appetite—Ifosfamide—testicular cancer	0.000808	0.00292	CcSEcCtD
Nizatidine—Headache—Vinblastine—testicular cancer	0.000807	0.00292	CcSEcCtD
Nizatidine—Gastrointestinal disorder—Ifosfamide—testicular cancer	0.000803	0.0029	CcSEcCtD
Nizatidine—Abdominal pain—Dactinomycin—testicular cancer	0.000802	0.0029	CcSEcCtD
Nizatidine—Body temperature increased—Dactinomycin—testicular cancer	0.000802	0.0029	CcSEcCtD
Nizatidine—Anaphylactic shock—Cisplatin—testicular cancer	0.000802	0.0029	CcSEcCtD
Nizatidine—Infection—Cisplatin—testicular cancer	0.000796	0.00288	CcSEcCtD
Nizatidine—Pain—Ifosfamide—testicular cancer	0.000795	0.00287	CcSEcCtD
Nizatidine—Constipation—Ifosfamide—testicular cancer	0.000795	0.00287	CcSEcCtD
Nizatidine—Cough—Etoposide—testicular cancer	0.000785	0.00284	CcSEcCtD
Nizatidine—Thrombocytopenia—Cisplatin—testicular cancer	0.000785	0.00284	CcSEcCtD
Nizatidine—Asthenia—Bleomycin—testicular cancer	0.000781	0.00282	CcSEcCtD
Nizatidine—Convulsion—Etoposide—testicular cancer	0.00078	0.00282	CcSEcCtD
Nizatidine—Hyperhidrosis—Cisplatin—testicular cancer	0.000775	0.0028	CcSEcCtD
Nizatidine—Pruritus—Bleomycin—testicular cancer	0.00077	0.00278	CcSEcCtD
Nizatidine—Feeling abnormal—Ifosfamide—testicular cancer	0.000766	0.00277	CcSEcCtD
Nizatidine—Chest pain—Etoposide—testicular cancer	0.000766	0.00277	CcSEcCtD
Nizatidine—Eosinophilia—Methotrexate—testicular cancer	0.000766	0.00277	CcSEcCtD
Nizatidine—Nausea—Vinblastine—testicular cancer	0.000765	0.00276	CcSEcCtD
Nizatidine—Anorexia—Cisplatin—testicular cancer	0.000764	0.00276	CcSEcCtD
Nizatidine—Gastrointestinal pain—Ifosfamide—testicular cancer	0.00076	0.00275	CcSEcCtD
Nizatidine—Nasopharyngitis—Epirubicin—testicular cancer	0.000749	0.00271	CcSEcCtD
Nizatidine—Confusional state—Etoposide—testicular cancer	0.00074	0.00268	CcSEcCtD
Nizatidine—Urticaria—Ifosfamide—testicular cancer	0.000739	0.00267	CcSEcCtD
Nizatidine—Abdominal pain—Ifosfamide—testicular cancer	0.000735	0.00266	CcSEcCtD
Nizatidine—Body temperature increased—Ifosfamide—testicular cancer	0.000735	0.00266	CcSEcCtD
Nizatidine—Anaphylactic shock—Etoposide—testicular cancer	0.000734	0.00265	CcSEcCtD
Nizatidine—Musculoskeletal discomfort—Cisplatin—testicular cancer	0.00073	0.00264	CcSEcCtD
Nizatidine—Infection—Etoposide—testicular cancer	0.00073	0.00264	CcSEcCtD
Nizatidine—Asthenia—Dactinomycin—testicular cancer	0.000728	0.00263	CcSEcCtD
Nizatidine—Thrombocytopenia—Etoposide—testicular cancer	0.000719	0.0026	CcSEcCtD
Nizatidine—Eosinophilia—Epirubicin—testicular cancer	0.000717	0.00259	CcSEcCtD
Nizatidine—Erectile dysfunction—Methotrexate—testicular cancer	0.000712	0.00257	CcSEcCtD
Nizatidine—Hyperhidrosis—Etoposide—testicular cancer	0.00071	0.00257	CcSEcCtD
Nizatidine—Anorexia—Etoposide—testicular cancer	0.0007	0.00253	CcSEcCtD
Nizatidine—Decreased appetite—Cisplatin—testicular cancer	0.000697	0.00252	CcSEcCtD
Nizatidine—Diarrhoea—Dactinomycin—testicular cancer	0.000694	0.00251	CcSEcCtD
Nizatidine—Pneumonia—Methotrexate—testicular cancer	0.000694	0.00251	CcSEcCtD
Nizatidine—Nasopharyngitis—Doxorubicin—testicular cancer	0.000693	0.0025	CcSEcCtD
Nizatidine—Gastrointestinal disorder—Cisplatin—testicular cancer	0.000692	0.0025	CcSEcCtD
Nizatidine—Vomiting—Bleomycin—testicular cancer	0.000692	0.0025	CcSEcCtD
Nizatidine—Rash—Bleomycin—testicular cancer	0.000686	0.00248	CcSEcCtD
Nizatidine—Pain—Cisplatin—testicular cancer	0.000685	0.00248	CcSEcCtD
Nizatidine—Dermatitis—Bleomycin—testicular cancer	0.000685	0.00248	CcSEcCtD
Nizatidine—Asthenia—Ifosfamide—testicular cancer	0.000667	0.00241	CcSEcCtD
Nizatidine—Eosinophilia—Doxorubicin—testicular cancer	0.000663	0.0024	CcSEcCtD
Nizatidine—Sweating—Methotrexate—testicular cancer	0.000661	0.00239	CcSEcCtD
Nizatidine—Feeling abnormal—Cisplatin—testicular cancer	0.000661	0.00239	CcSEcCtD
Nizatidine—Pruritus—Ifosfamide—testicular cancer	0.000658	0.00238	CcSEcCtD
Nizatidine—Somnolence—Etoposide—testicular cancer	0.000653	0.00236	CcSEcCtD
Nizatidine—Pneumonia—Epirubicin—testicular cancer	0.000649	0.00235	CcSEcCtD
Nizatidine—Nausea—Bleomycin—testicular cancer	0.000646	0.00234	CcSEcCtD
Nizatidine—Vomiting—Dactinomycin—testicular cancer	0.000645	0.00233	CcSEcCtD
Nizatidine—Rash—Dactinomycin—testicular cancer	0.00064	0.00231	CcSEcCtD
Nizatidine—Decreased appetite—Etoposide—testicular cancer	0.000638	0.00231	CcSEcCtD
Nizatidine—Diarrhoea—Ifosfamide—testicular cancer	0.000636	0.0023	CcSEcCtD
Nizatidine—Gastrointestinal disorder—Etoposide—testicular cancer	0.000634	0.00229	CcSEcCtD
Nizatidine—Body temperature increased—Cisplatin—testicular cancer	0.000634	0.00229	CcSEcCtD
Nizatidine—Jaundice—Epirubicin—testicular cancer	0.000629	0.00227	CcSEcCtD
Nizatidine—Pain—Etoposide—testicular cancer	0.000628	0.00227	CcSEcCtD
Nizatidine—Constipation—Etoposide—testicular cancer	0.000628	0.00227	CcSEcCtD
Nizatidine—Hepatitis—Methotrexate—testicular cancer	0.000619	0.00224	CcSEcCtD
Nizatidine—Sweating—Epirubicin—testicular cancer	0.000619	0.00224	CcSEcCtD
Nizatidine—Dizziness—Ifosfamide—testicular cancer	0.000615	0.00222	CcSEcCtD
Nizatidine—Pharyngitis—Methotrexate—testicular cancer	0.000615	0.00222	CcSEcCtD
Nizatidine—Sinusitis—Epirubicin—testicular cancer	0.000606	0.00219	CcSEcCtD
Nizatidine—Feeling abnormal—Etoposide—testicular cancer	0.000605	0.00219	CcSEcCtD
Nizatidine—Nausea—Dactinomycin—testicular cancer	0.000603	0.00218	CcSEcCtD
Nizatidine—Pneumonia—Doxorubicin—testicular cancer	0.000601	0.00217	CcSEcCtD
Nizatidine—Gastrointestinal pain—Etoposide—testicular cancer	0.000601	0.00217	CcSEcCtD
Nizatidine—Vomiting—Ifosfamide—testicular cancer	0.000591	0.00214	CcSEcCtD
Nizatidine—Rash—Ifosfamide—testicular cancer	0.000586	0.00212	CcSEcCtD
Nizatidine—Dermatitis—Ifosfamide—testicular cancer	0.000586	0.00212	CcSEcCtD
Nizatidine—Urticaria—Etoposide—testicular cancer	0.000583	0.00211	CcSEcCtD
Nizatidine—Jaundice—Doxorubicin—testicular cancer	0.000582	0.0021	CcSEcCtD
Nizatidine—Rhinitis—Epirubicin—testicular cancer	0.000581	0.0021	CcSEcCtD
Nizatidine—Abdominal pain—Etoposide—testicular cancer	0.000581	0.0021	CcSEcCtD
Nizatidine—Body temperature increased—Etoposide—testicular cancer	0.000581	0.0021	CcSEcCtD
Nizatidine—Hepatitis—Epirubicin—testicular cancer	0.000579	0.00209	CcSEcCtD
Nizatidine—Asthenia—Cisplatin—testicular cancer	0.000575	0.00208	CcSEcCtD
Nizatidine—Pharyngitis—Epirubicin—testicular cancer	0.000575	0.00208	CcSEcCtD
Nizatidine—Sweating—Doxorubicin—testicular cancer	0.000573	0.00207	CcSEcCtD
Nizatidine—Sinusitis—Doxorubicin—testicular cancer	0.00056	0.00202	CcSEcCtD
Nizatidine—Nausea—Ifosfamide—testicular cancer	0.000552	0.002	CcSEcCtD
Nizatidine—Diarrhoea—Cisplatin—testicular cancer	0.000548	0.00198	CcSEcCtD
Nizatidine—Rhinitis—Doxorubicin—testicular cancer	0.000537	0.00194	CcSEcCtD
Nizatidine—Hepatitis—Doxorubicin—testicular cancer	0.000536	0.00194	CcSEcCtD
Nizatidine—Pharyngitis—Doxorubicin—testicular cancer	0.000532	0.00192	CcSEcCtD
Nizatidine—Asthenia—Etoposide—testicular cancer	0.000527	0.0019	CcSEcCtD
Nizatidine—Back pain—Methotrexate—testicular cancer	0.000521	0.00188	CcSEcCtD
Nizatidine—Pruritus—Etoposide—testicular cancer	0.00052	0.00188	CcSEcCtD
Nizatidine—Vomiting—Cisplatin—testicular cancer	0.00051	0.00184	CcSEcCtD
Nizatidine—Rash—Cisplatin—testicular cancer	0.000505	0.00183	CcSEcCtD
Nizatidine—Dermatitis—Cisplatin—testicular cancer	0.000505	0.00182	CcSEcCtD
Nizatidine—Diarrhoea—Etoposide—testicular cancer	0.000502	0.00182	CcSEcCtD
Nizatidine—Anaemia—Methotrexate—testicular cancer	0.000498	0.0018	CcSEcCtD
Nizatidine—Flatulence—Epirubicin—testicular cancer	0.000497	0.0018	CcSEcCtD
Nizatidine—Tension—Epirubicin—testicular cancer	0.000495	0.00179	CcSEcCtD
Nizatidine—Nervousness—Epirubicin—testicular cancer	0.00049	0.00177	CcSEcCtD
Nizatidine—Back pain—Epirubicin—testicular cancer	0.000488	0.00176	CcSEcCtD
Nizatidine—Dizziness—Etoposide—testicular cancer	0.000486	0.00175	CcSEcCtD
Nizatidine—Nausea—Cisplatin—testicular cancer	0.000476	0.00172	CcSEcCtD
Nizatidine—Cough—Methotrexate—testicular cancer	0.00047	0.0017	CcSEcCtD
Nizatidine—Convulsion—Methotrexate—testicular cancer	0.000467	0.00169	CcSEcCtD
Nizatidine—Vomiting—Etoposide—testicular cancer	0.000467	0.00169	CcSEcCtD
Nizatidine—Anaemia—Epirubicin—testicular cancer	0.000466	0.00168	CcSEcCtD
Nizatidine—Rash—Etoposide—testicular cancer	0.000463	0.00167	CcSEcCtD
Nizatidine—Dermatitis—Etoposide—testicular cancer	0.000463	0.00167	CcSEcCtD
Nizatidine—Headache—Etoposide—testicular cancer	0.00046	0.00166	CcSEcCtD
Nizatidine—Flatulence—Doxorubicin—testicular cancer	0.00046	0.00166	CcSEcCtD
Nizatidine—Myalgia—Methotrexate—testicular cancer	0.000459	0.00166	CcSEcCtD
Nizatidine—Chest pain—Methotrexate—testicular cancer	0.000459	0.00166	CcSEcCtD
Nizatidine—Tension—Doxorubicin—testicular cancer	0.000458	0.00165	CcSEcCtD
Nizatidine—Nervousness—Doxorubicin—testicular cancer	0.000453	0.00164	CcSEcCtD
Nizatidine—Back pain—Doxorubicin—testicular cancer	0.000451	0.00163	CcSEcCtD
Nizatidine—Confusional state—Methotrexate—testicular cancer	0.000444	0.0016	CcSEcCtD
Nizatidine—Cough—Epirubicin—testicular cancer	0.00044	0.00159	CcSEcCtD
Nizatidine—Anaphylactic shock—Methotrexate—testicular cancer	0.00044	0.00159	CcSEcCtD
Nizatidine—Convulsion—Epirubicin—testicular cancer	0.000437	0.00158	CcSEcCtD
Nizatidine—Infection—Methotrexate—testicular cancer	0.000437	0.00158	CcSEcCtD
Nizatidine—Nausea—Etoposide—testicular cancer	0.000436	0.00158	CcSEcCtD
Nizatidine—Anaemia—Doxorubicin—testicular cancer	0.000431	0.00156	CcSEcCtD
Nizatidine—Thrombocytopenia—Methotrexate—testicular cancer	0.000431	0.00156	CcSEcCtD
Nizatidine—Chest pain—Epirubicin—testicular cancer	0.000429	0.00155	CcSEcCtD
Nizatidine—Myalgia—Epirubicin—testicular cancer	0.000429	0.00155	CcSEcCtD
Nizatidine—Anxiety—Epirubicin—testicular cancer	0.000428	0.00155	CcSEcCtD
Nizatidine—Hyperhidrosis—Methotrexate—testicular cancer	0.000425	0.00154	CcSEcCtD
Nizatidine—Dry mouth—Epirubicin—testicular cancer	0.00042	0.00152	CcSEcCtD
Nizatidine—Anorexia—Methotrexate—testicular cancer	0.000419	0.00152	CcSEcCtD
Nizatidine—Confusional state—Epirubicin—testicular cancer	0.000415	0.0015	CcSEcCtD
Nizatidine—Anaphylactic shock—Epirubicin—testicular cancer	0.000412	0.00149	CcSEcCtD
Nizatidine—Infection—Epirubicin—testicular cancer	0.000409	0.00148	CcSEcCtD
Nizatidine—Cough—Doxorubicin—testicular cancer	0.000407	0.00147	CcSEcCtD
Nizatidine—Convulsion—Doxorubicin—testicular cancer	0.000404	0.00146	CcSEcCtD
Nizatidine—Thrombocytopenia—Epirubicin—testicular cancer	0.000403	0.00146	CcSEcCtD
Nizatidine—Musculoskeletal discomfort—Methotrexate—testicular cancer	0.000401	0.00145	CcSEcCtD
Nizatidine—Hyperhidrosis—Epirubicin—testicular cancer	0.000398	0.00144	CcSEcCtD
Nizatidine—Insomnia—Methotrexate—testicular cancer	0.000398	0.00144	CcSEcCtD
Nizatidine—Chest pain—Doxorubicin—testicular cancer	0.000397	0.00144	CcSEcCtD
Nizatidine—Myalgia—Doxorubicin—testicular cancer	0.000397	0.00144	CcSEcCtD
Nizatidine—Anxiety—Doxorubicin—testicular cancer	0.000396	0.00143	CcSEcCtD
Nizatidine—Anorexia—Epirubicin—testicular cancer	0.000392	0.00142	CcSEcCtD
Nizatidine—Somnolence—Methotrexate—testicular cancer	0.000391	0.00141	CcSEcCtD
Nizatidine—Dry mouth—Doxorubicin—testicular cancer	0.000389	0.0014	CcSEcCtD
Nizatidine—Dyspepsia—Methotrexate—testicular cancer	0.000387	0.0014	CcSEcCtD
Nizatidine—Confusional state—Doxorubicin—testicular cancer	0.000384	0.00139	CcSEcCtD
Nizatidine—Decreased appetite—Methotrexate—testicular cancer	0.000382	0.00138	CcSEcCtD
Nizatidine—Anaphylactic shock—Doxorubicin—testicular cancer	0.000381	0.00138	CcSEcCtD
Nizatidine—Gastrointestinal disorder—Methotrexate—testicular cancer	0.00038	0.00137	CcSEcCtD
Nizatidine—Infection—Doxorubicin—testicular cancer	0.000378	0.00137	CcSEcCtD
Nizatidine—Pain—Methotrexate—testicular cancer	0.000376	0.00136	CcSEcCtD
Nizatidine—Musculoskeletal discomfort—Epirubicin—testicular cancer	0.000375	0.00136	CcSEcCtD
Nizatidine—Thrombocytopenia—Doxorubicin—testicular cancer	0.000373	0.00135	CcSEcCtD
Nizatidine—Insomnia—Epirubicin—testicular cancer	0.000372	0.00135	CcSEcCtD
Nizatidine—Hyperhidrosis—Doxorubicin—testicular cancer	0.000368	0.00133	CcSEcCtD
Nizatidine—Somnolence—Epirubicin—testicular cancer	0.000366	0.00132	CcSEcCtD
Nizatidine—Anorexia—Doxorubicin—testicular cancer	0.000363	0.00131	CcSEcCtD
Nizatidine—Feeling abnormal—Methotrexate—testicular cancer	0.000362	0.00131	CcSEcCtD
Nizatidine—Dyspepsia—Epirubicin—testicular cancer	0.000362	0.00131	CcSEcCtD
Nizatidine—Gastrointestinal pain—Methotrexate—testicular cancer	0.00036	0.0013	CcSEcCtD
Nizatidine—Decreased appetite—Epirubicin—testicular cancer	0.000358	0.00129	CcSEcCtD
Nizatidine—Gastrointestinal disorder—Epirubicin—testicular cancer	0.000355	0.00128	CcSEcCtD
Nizatidine—Constipation—Epirubicin—testicular cancer	0.000352	0.00127	CcSEcCtD
Nizatidine—Pain—Epirubicin—testicular cancer	0.000352	0.00127	CcSEcCtD
Nizatidine—Urticaria—Methotrexate—testicular cancer	0.000349	0.00126	CcSEcCtD
Nizatidine—Abdominal pain—Methotrexate—testicular cancer	0.000348	0.00126	CcSEcCtD
Nizatidine—Body temperature increased—Methotrexate—testicular cancer	0.000348	0.00126	CcSEcCtD
Nizatidine—Musculoskeletal discomfort—Doxorubicin—testicular cancer	0.000347	0.00125	CcSEcCtD
Nizatidine—Insomnia—Doxorubicin—testicular cancer	0.000345	0.00124	CcSEcCtD
Nizatidine—Feeling abnormal—Epirubicin—testicular cancer	0.000339	0.00123	CcSEcCtD
Nizatidine—Somnolence—Doxorubicin—testicular cancer	0.000339	0.00122	CcSEcCtD
Nizatidine—Gastrointestinal pain—Epirubicin—testicular cancer	0.000337	0.00122	CcSEcCtD
Nizatidine—Dyspepsia—Doxorubicin—testicular cancer	0.000335	0.00121	CcSEcCtD
Nizatidine—Decreased appetite—Doxorubicin—testicular cancer	0.000331	0.0012	CcSEcCtD
Nizatidine—Gastrointestinal disorder—Doxorubicin—testicular cancer	0.000329	0.00119	CcSEcCtD
Nizatidine—Urticaria—Epirubicin—testicular cancer	0.000327	0.00118	CcSEcCtD
Nizatidine—Constipation—Doxorubicin—testicular cancer	0.000326	0.00118	CcSEcCtD
Nizatidine—Pain—Doxorubicin—testicular cancer	0.000326	0.00118	CcSEcCtD
Nizatidine—Body temperature increased—Epirubicin—testicular cancer	0.000325	0.00118	CcSEcCtD
Nizatidine—Abdominal pain—Epirubicin—testicular cancer	0.000325	0.00118	CcSEcCtD
Nizatidine—Asthenia—Methotrexate—testicular cancer	0.000316	0.00114	CcSEcCtD
Nizatidine—Feeling abnormal—Doxorubicin—testicular cancer	0.000314	0.00113	CcSEcCtD
Nizatidine—Gastrointestinal pain—Doxorubicin—testicular cancer	0.000311	0.00113	CcSEcCtD
Nizatidine—Pruritus—Methotrexate—testicular cancer	0.000311	0.00112	CcSEcCtD
Nizatidine—Urticaria—Doxorubicin—testicular cancer	0.000303	0.00109	CcSEcCtD
Nizatidine—Abdominal pain—Doxorubicin—testicular cancer	0.000301	0.00109	CcSEcCtD
Nizatidine—Body temperature increased—Doxorubicin—testicular cancer	0.000301	0.00109	CcSEcCtD
Nizatidine—Diarrhoea—Methotrexate—testicular cancer	0.000301	0.00109	CcSEcCtD
Nizatidine—Asthenia—Epirubicin—testicular cancer	0.000295	0.00107	CcSEcCtD
Nizatidine—Pruritus—Epirubicin—testicular cancer	0.000291	0.00105	CcSEcCtD
Nizatidine—Dizziness—Methotrexate—testicular cancer	0.000291	0.00105	CcSEcCtD
Nizatidine—Diarrhoea—Epirubicin—testicular cancer	0.000282	0.00102	CcSEcCtD
Nizatidine—Vomiting—Methotrexate—testicular cancer	0.00028	0.00101	CcSEcCtD
Nizatidine—Rash—Methotrexate—testicular cancer	0.000277	0.001	CcSEcCtD
Nizatidine—Dermatitis—Methotrexate—testicular cancer	0.000277	0.001	CcSEcCtD
Nizatidine—Headache—Methotrexate—testicular cancer	0.000276	0.000996	CcSEcCtD
Nizatidine—Asthenia—Doxorubicin—testicular cancer	0.000273	0.000987	CcSEcCtD
Nizatidine—Dizziness—Epirubicin—testicular cancer	0.000272	0.000984	CcSEcCtD
Nizatidine—Pruritus—Doxorubicin—testicular cancer	0.000269	0.000974	CcSEcCtD
Nizatidine—Vomiting—Epirubicin—testicular cancer	0.000262	0.000946	CcSEcCtD
Nizatidine—Nausea—Methotrexate—testicular cancer	0.000261	0.000944	CcSEcCtD
Nizatidine—Diarrhoea—Doxorubicin—testicular cancer	0.000261	0.000942	CcSEcCtD
Nizatidine—Rash—Epirubicin—testicular cancer	0.00026	0.000938	CcSEcCtD
Nizatidine—Dermatitis—Epirubicin—testicular cancer	0.000259	0.000937	CcSEcCtD
Nizatidine—Headache—Epirubicin—testicular cancer	0.000258	0.000932	CcSEcCtD
Nizatidine—Dizziness—Doxorubicin—testicular cancer	0.000252	0.00091	CcSEcCtD
Nizatidine—Nausea—Epirubicin—testicular cancer	0.000245	0.000884	CcSEcCtD
Nizatidine—Vomiting—Doxorubicin—testicular cancer	0.000242	0.000875	CcSEcCtD
Nizatidine—Rash—Doxorubicin—testicular cancer	0.00024	0.000868	CcSEcCtD
Nizatidine—Dermatitis—Doxorubicin—testicular cancer	0.00024	0.000867	CcSEcCtD
Nizatidine—Headache—Doxorubicin—testicular cancer	0.000239	0.000862	CcSEcCtD
Nizatidine—Nausea—Doxorubicin—testicular cancer	0.000226	0.000818	CcSEcCtD
